<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p75" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_75{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_75{left:341px;bottom:30px;}
#t3_75{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_75{left:377px;bottom:30px;}
#t5_75{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_75{left:540px;bottom:30px;}
#t7_75{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_75{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_75{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_75{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_75{left:285px;bottom:827px;letter-spacing:-0.25px;}
#tc_75{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_75{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_75{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_75{left:1120px;bottom:28px;letter-spacing:0.24px;}
#tg_75{left:36px;bottom:198px;}
#th_75{left:46px;bottom:192px;letter-spacing:0.13px;}
#ti_75{left:261px;bottom:192px;}
#tj_75{left:36px;bottom:181px;}
#tk_75{left:46px;bottom:175px;letter-spacing:0.13px;word-spacing:-0.06px;}
#tl_75{left:322px;bottom:175px;}
#tm_75{left:36px;bottom:164px;}
#tn_75{left:46px;bottom:158px;letter-spacing:0.11px;word-spacing:0.02px;}
#to_75{left:255px;bottom:158px;letter-spacing:0.14px;}
#tp_75{left:326px;bottom:158px;letter-spacing:0.13px;}
#tq_75{left:607px;bottom:158px;letter-spacing:0.04px;}
#tr_75{left:688px;bottom:158px;letter-spacing:0.12px;}
#ts_75{left:718px;bottom:158px;letter-spacing:0.06px;}
#tt_75{left:795px;bottom:158px;letter-spacing:0.11px;word-spacing:0.02px;}
#tu_75{left:45px;bottom:142px;letter-spacing:0.12px;}
#tv_75{left:36px;bottom:131px;}
#tw_75{left:46px;bottom:125px;letter-spacing:0.12px;word-spacing:-0.03px;}
#tx_75{left:556px;bottom:125px;}
#ty_75{left:36px;bottom:114px;}
#tz_75{left:43px;bottom:108px;letter-spacing:0.12px;}
#t10_75{left:75px;bottom:108px;letter-spacing:0.12px;}
#t11_75{left:153px;bottom:108px;letter-spacing:0.08px;word-spacing:0.05px;}
#t12_75{left:36px;bottom:778px;letter-spacing:0.42px;}
#t13_75{left:262px;bottom:778px;letter-spacing:0.38px;word-spacing:-0.21px;}
#t14_75{left:472px;bottom:786px;}
#t15_75{left:36px;bottom:562px;letter-spacing:-0.09px;}
#t16_75{left:36px;bottom:544px;letter-spacing:-0.09px;}
#t17_75{left:36px;bottom:526px;letter-spacing:-0.09px;}
#t18_75{left:36px;bottom:507px;letter-spacing:-0.09px;}
#t19_75{left:36px;bottom:489px;letter-spacing:-0.09px;}
#t1a_75{left:36px;bottom:471px;letter-spacing:-0.08px;}
#t1b_75{left:36px;bottom:452px;letter-spacing:-0.1px;}
#t1c_75{left:36px;bottom:434px;letter-spacing:-0.1px;}
#t1d_75{left:36px;bottom:416px;letter-spacing:-0.11px;}
#t1e_75{left:120px;bottom:423px;}
#t1f_75{left:383px;bottom:437px;letter-spacing:-0.1px;}
#t1g_75{left:511px;bottom:445px;}
#t1h_75{left:383px;bottom:405px;letter-spacing:-0.1px;}
#t1i_75{left:383px;bottom:373px;letter-spacing:-0.1px;}
#t1j_75{left:643px;bottom:381px;letter-spacing:-0.12px;}
#t1k_75{left:383px;bottom:355px;letter-spacing:-0.1px;}
#t1l_75{left:383px;bottom:323px;letter-spacing:-0.1px;}
#t1m_75{left:383px;bottom:291px;letter-spacing:-0.1px;}
#t1n_75{left:579px;bottom:298px;letter-spacing:-0.11px;}
#t1o_75{left:602px;bottom:291px;letter-spacing:-0.08px;}
#t1p_75{left:383px;bottom:272px;letter-spacing:-0.1px;}
#t1q_75{left:645px;bottom:280px;letter-spacing:-0.12px;}
#t1r_75{left:671px;bottom:272px;letter-spacing:-0.1px;}
#t1s_75{left:715px;bottom:280px;}
#t1t_75{left:383px;bottom:661px;letter-spacing:-0.1px;}
#t1u_75{left:511px;bottom:669px;}
#t1v_75{left:383px;bottom:629px;letter-spacing:-0.1px;}
#t1w_75{left:383px;bottom:597px;letter-spacing:-0.13px;}
#t1x_75{left:406px;bottom:604px;}
#t1y_75{left:418px;bottom:597px;letter-spacing:-0.1px;}
#t1z_75{left:766px;bottom:660px;letter-spacing:-0.12px;}
#t20_75{left:766px;bottom:437px;letter-spacing:-0.12px;}
#t21_75{left:1022px;bottom:342px;letter-spacing:-0.09px;}
#t22_75{left:1022px;bottom:324px;letter-spacing:-0.09px;}
#t23_75{left:1022px;bottom:306px;letter-spacing:-0.25px;}
#t24_75{left:1022px;bottom:615px;letter-spacing:-0.09px;}
#t25_75{left:1022px;bottom:596px;letter-spacing:-0.09px;}
#t26_75{left:1022px;bottom:578px;letter-spacing:-0.25px;}
#t27_75{left:251px;bottom:627px;letter-spacing:-0.12px;}
#t28_75{left:244px;bottom:355px;letter-spacing:-0.12px;}
#t29_75{left:766px;bottom:617px;letter-spacing:-0.1px;}
#t2a_75{left:766px;bottom:596px;letter-spacing:-0.1px;}
#t2b_75{left:766px;bottom:576px;letter-spacing:-0.09px;}
#t2c_75{left:766px;bottom:342px;letter-spacing:-0.1px;}
#t2d_75{left:766px;bottom:322px;letter-spacing:-0.1px;}
#t2e_75{left:766px;bottom:302px;letter-spacing:-0.09px;}
#t2f_75{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_75{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_75{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_75{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_75{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_75{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_75{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_75{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_75{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_75{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_75{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_75{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sb_75{font-size:14px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_75{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sd_75{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts75" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg75Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg75" style="-webkit-user-select: none;"><object width="1210" height="935" data="75/75.svg" type="image/svg+xml" id="pdf75" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_75" class="t s0_75">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_75" class="t s1_75">® </span>
<span id="t3_75" class="t s0_75">(NCCN </span>
<span id="t4_75" class="t s1_75">® </span>
<span id="t5_75" class="t s0_75">), All rights reserved. NCCN Guidelines </span>
<span id="t6_75" class="t s1_75">® </span>
<span id="t7_75" class="t s0_75">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_75" class="t s2_75">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_75" class="t s2_75">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_75" class="t s3_75">NCCN Guidelines Version 4.2024 </span>
<span id="tb_75" class="t s3_75">Occult Primary </span>
<span id="tc_75" class="t s4_75">NCCN Guidelines Index </span>
<span id="td_75" class="t s4_75">Table of Contents </span>
<span id="te_75" class="t s4_75">Discussion </span>
<span id="tf_75" class="t s5_75">OCC-3 </span>
<span id="tg_75" class="t s6_75">n </span>
<span id="th_75" class="t s7_75">Principles of Surgery (SURG-A)</span><span id="ti_75" class="t s8_75">. </span>
<span id="tj_75" class="t s6_75">o </span>
<span id="tk_75" class="t s7_75">Principles of Radiation Therapy (OCC-A)</span><span id="tl_75" class="t s8_75">. </span>
<span id="tm_75" class="t s6_75">p </span>
<span id="tn_75" class="t s8_75">Treatment for nasopharyngeal </span><span id="to_75" class="t s7_75">(NASO-2) </span><span id="tp_75" class="t s8_75">and p16-positive oropharyngeal cancers (</span><span id="tq_75" class="t s7_75">ORPHPV-3 </span><span id="tr_75" class="t s8_75">and </span><span id="ts_75" class="t s7_75">ORPHPV-4</span><span id="tt_75" class="t s8_75">) to guide management of EBV-positive and p16- </span>
<span id="tu_75" class="t s8_75">positive occult primary tumors. </span>
<span id="tv_75" class="t s6_75">q </span>
<span id="tw_75" class="t s7_75">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="tx_75" class="t s8_75">. </span>
<span id="ty_75" class="t s6_75">r </span>
<span id="tz_75" class="t s8_75">See </span><span id="t10_75" class="t s7_75">Discussion </span><span id="t11_75" class="t s8_75">on induction chemotherapy. </span>
<span id="t12_75" class="t s5_75">HISTOLOGY </span><span id="t13_75" class="t s5_75">DEFINITIVE TREATMENT </span>
<span id="t14_75" class="t s9_75">p </span>
<span id="t15_75" class="t s5_75">Poorly </span>
<span id="t16_75" class="t sa_75" data-mappings='[[2,"ff"]]'>diﬀerentiated or </span>
<span id="t17_75" class="t s5_75">nonkeratinizing </span>
<span id="t18_75" class="t sa_75">squamous cell or </span>
<span id="t19_75" class="t s5_75">NOS or anaplastic </span>
<span id="t1a_75" class="t s5_75">(not thyroid) </span>
<span id="t1b_75" class="t s5_75">or </span>
<span id="t1c_75" class="t sa_75">Squamous cell </span>
<span id="t1d_75" class="t s5_75">carcinoma </span>
<span id="t1e_75" class="t s9_75">p </span>
<span id="t1f_75" class="t s5_75">Neck dissection </span>
<span id="t1g_75" class="t s9_75">n </span>
<span id="t1h_75" class="t s5_75">or </span>
<span id="t1i_75" class="t s5_75">Concurrent systemic therapy/RT </span>
<span id="t1j_75" class="t sb_75">o,q </span>
<span id="t1k_75" class="t s5_75">(category 2B) </span>
<span id="t1l_75" class="t s5_75">or </span>
<span id="t1m_75" class="t s5_75">Induction chemotherapy </span>
<span id="t1n_75" class="t sb_75">q,r </span>
<span id="t1o_75" class="t s5_75">(category 3) </span>
<span id="t1p_75" class="t s5_75">followed by systemic therapy/RT </span>
<span id="t1q_75" class="t sb_75">o,q </span>
<span id="t1r_75" class="t s5_75">or RT </span>
<span id="t1s_75" class="t s9_75">o </span>
<span id="t1t_75" class="t s5_75">Neck dissection </span>
<span id="t1u_75" class="t s9_75">n </span>
<span id="t1v_75" class="t s5_75">or </span>
<span id="t1w_75" class="t s5_75">RT </span>
<span id="t1x_75" class="t s9_75">o </span>
<span id="t1y_75" class="t s5_75">(category 2B) </span>
<span id="t1z_75" class="t sc_75">OCC-4 </span>
<span id="t20_75" class="t sc_75">OCC-4 </span>
<span id="t21_75" class="t s5_75">Recurrent or </span>
<span id="t22_75" class="t s5_75">persistent disease </span>
<span id="t23_75" class="t sc_75">(ADV-3) </span>
<span id="t24_75" class="t s5_75">Recurrent or </span>
<span id="t25_75" class="t s5_75">persistent disease </span>
<span id="t26_75" class="t sc_75">(ADV-3) </span>
<span id="t27_75" class="t s5_75">N1 </span>
<span id="t28_75" class="t s5_75">N2–3 </span>
<span id="t29_75" class="t sc_75">Post Systemic Therapy/ </span>
<span id="t2a_75" class="t sc_75">RT or RT Neck Evaluation </span>
<span id="t2b_75" class="t sc_75">(FOLL-A, 2 of 2) </span>
<span id="t2c_75" class="t sc_75">Post Systemic Therapy/ </span>
<span id="t2d_75" class="t sc_75">RT or RT Neck Evaluation </span>
<span id="t2e_75" class="t sc_75">(FOLL-A, 2 of 2) </span>
<span id="t2f_75" class="t sd_75">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
